Table 2.
18F-FDG PET/CT parameters between patients with pCR-T and non-pCR-T
| Parameters | pCR-T (n = 15) | non-pCR-T (n = 29) | P value |
|---|---|---|---|
| Mean (IQR) | |||
| SUVmax-Tpre | 20.76(16.82,25.63) | 19.94(16.82,25.13) | 0.78 |
| MTV-Tpre | 18.06(10.95,36.03) | 22.44(14.21,29.58) | 0.59 |
| TLG-Tpre | 173.42(64.96,339.75) | 196.60(116.30,270.60) | 0.59 |
| SUVmax-Tpost | 4.19(3.28,4.73) | 5.65(3.99,8.76) | 0.02 |
| MTV-Tpost | 2.28(1.15,3.55) | 5.23(2.94,6.89) | 0.00 |
| TLG-Tpost | 6.97(3.74,11.62) | 17.13(9.09,28.30) | 0.00 |
| ΔSUVmax-T | − 0.80(− 0.76, − 0.85) | − 0.70(− 0.58, − 0.79) | 0.01 |
| ΔMTV-T | − 0.90(− 0.66, − 0.95) | − 0.77(− 0.63, − 0.86) | 0.04 |
| ΔTLG-T | − 0.96(− 0.81, − 0.99) | − 0.89(− 0.87, − 0.95) | 0.07 |
P values less than 0.05 are indicated in bold italics
18F-FDG-PET/CT 18F-Fluorodeoxyglucose-positron emission tomography/computed tomography; pCR-T complete response of primary tumor; SUVmax maximum standard uptake value; MTV metabolic tumor volume; TLG total lesion glycolysis